The Court held that all claims of three related veterinary vaccine patent applications were invalid on various grounds including lack of inventive step, lack of support and disclosure, and failure to disclose best method. The Court found that dependent claims claiming single-dose administration or addition of adjuvants did not add inventive features to already obvious independent claims. The Court clarified that inventiveness must be assessed for each claim as a whole, not by considering additional integers in isolation.
The full text is available to signed-in members, including the 2 later cases that cite this judgment.